|
[1]
|
中华医学会神经病学分会, 中华医学会神经病学分会周围神经病协作组, 中华医学会神经病学分会肌电图与临床神经电生理学组, 等. 中国吉兰-巴雷综合征诊治指南2019[J]. 中华神经科杂志, 2019, 52(11): 877-882.
|
|
[2]
|
Pham, H.P., Staley, E.M. and Schwartz, J. (2019) Therapeutic Plasma Exchange—A Brief Review of Indications, Urgency, Schedule, and Technical Aspects. Transfusion and Apheresis Science, 58, 237-246. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Saccà, F., Pane, C., Espinosa, P.E., Sormani, M.P. and Signori, A. (2023) Efficacy of Innovative Therapies in Myasthenia Gravis: A Systematic Review, Meta-Analysis and Network Meta-Analysis. European Journal of Neurology, 30, 3854-3867. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Shahrizaila, N., Lehmann, H.C. and Kuwabara, S. (2021) Guillain-Barré Syndrome. The Lancet, 397, 1214-1228. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Guo, F., Yao, Q., Wu, X., Guo, H., Su, X., Zhou, J., et al. (2025) Clinical Characteristics of Guillain-Barré Syndrome in Shenzhen: A Retrospective Study. BMC Neurology, 25, Article No. 72. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Nakamura, T. (2008) Infectious Agents as the Triggers for the Pathogenesis of the Neuroimmunological Disorders. Nihon rinsho: Japanese Journal of Clinical Medicine, 66, 1056-1064.
|
|
[7]
|
Rees, J.H., Soudain, S.E., Gregson, N.A., et al. (1995) Campylobacter Jejuni Infection and Guillain-Barré Syndrome. The New England Journal of Medicine, 333, 1374-1379.
|
|
[8]
|
Ginanneschi, F., Giannini, F., Sicurelli, F., Battisti, C., Capoccitti, G., Bartalini, S., et al. (2022) Clinical Features and Outcome of the Guillain-Barre Syndrome: A Single-Center 11-Year Experience. Frontiers in Neurology, 13, Article 856091. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Hanchosky, A.M., Hellmann, E., Chong, C. and Sarvepalli, S. (2025) Guillain-Barré Syndrome Induced by Mycoplasma pneumoniae: A Non-Classical Presentation. Cureus, 17, e83538. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Cordeiro de Souza, L., Souza, A.A.D., Almeida, E.E.P.D., Honse Ribeiro, L., Parada Godoy, M.D., Augusto Junior, W., et al. (2018) Inspiratory Muscle Training with Isokinetic Device to Help Ventilatory Weaning in a Patient with Guillain-Barré Syndrome by Zika Virus. Case Reports in Critical Care, 2018, 1-5. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Abdulmana, S., Al-Zahrani, N., Sharahely, Y., et al. (2021) Fulminant Guillain-Barré Syndrome Post Hemorrhagic Stroke: Two Case Reports. Neurology International, 13, 190-194. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Fokke, C., van den Berg, B., Drenthen, J., Walgaard, C., van Doorn, P.A. and Jacobs, B.C. (2014) Diagnosis of Guillain-Barre Syndrome and Validation of Brighton Criteria. Brain, 137, 33-43. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
黄诚, 秦新月. 抗GQ1b抗体综合征的研究进展[J]. 中华神经科杂志, 2016, 49(1): 75-78.
|
|
[14]
|
杨欣英, 韩彤立, 张炜华, 等. 抗GQ1b抗体综合征四例临床分析[J]. 中华儿科杂志, 2017, 55(12): 947-952.
|
|
[15]
|
Bellanti, R. and Rinaldi, S. (2024) Guillain‐Barré Syndrome: A Comprehensive Review. European Journal of Neurology, 31, e16365. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Raphaël, J.C., Chevret, S., Hughes, R.A., et al. (2002) Plasma Exchange for Guillain-Barré Syndrome. The Cochrane Database of Systematic Reviews, 2, CD001798.
|
|
[17]
|
Kuitwaard, K., de Gelder, J., Tio‐Gillen, A.P., Hop, W.C.J., van Gelder, T., van Toorenenbergen, A.W., et al. (2009) Pharmacokinetics of Intravenous Immunoglobulin and Outcome in Guillain-Barré Syndrome. Annals of Neurology, 66, 597-603. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group (1997) Randomised Trial of Plasma Exchange, Intravenous Immunoglobulin, and Combined Treatments in Guillain-Barré Syndrome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. The Lancet, 349, 225-230.
|
|
[19]
|
Neumeister, J., Huang, D., Dzluneski, S., Huttleston, A.M., Megargel, C., Falgiani, M., et al. (2023) Hyperacute and Fulminant Guillain-Barré Syndrome Requiring Emergent Intubation. Cureus, 15, e38499. [Google Scholar] [CrossRef] [PubMed]
|